nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.112	0.17	CbGbCtD
Oxymorphone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.112	0.17	CbGbCtD
Oxymorphone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.1	0.152	CbGbCtD
Oxymorphone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0942	0.143	CbGbCtD
Oxymorphone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0637	0.0966	CbGbCtD
Oxymorphone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0607	0.0921	CbGbCtD
Oxymorphone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0541	0.0821	CbGbCtD
Oxymorphone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0318	0.0482	CbGbCtD
Oxymorphone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.03	0.0455	CbGbCtD
Oxymorphone—Naloxone—TLR4—chronic obstructive pulmonary disease	0.00537	0.745	CrCbGaD
Oxymorphone—Buprenorphine—CYP1A2—chronic obstructive pulmonary disease	0.00117	0.162	CrCbGaD
Oxymorphone—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000851	0.00285	CcSEcCtD
Oxymorphone—Tension—Formoterol—chronic obstructive pulmonary disease	0.00085	0.00284	CcSEcCtD
Oxymorphone—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00085	0.00284	CcSEcCtD
Oxymorphone—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000849	0.00284	CcSEcCtD
Oxymorphone—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000847	0.00283	CcSEcCtD
Oxymorphone—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000841	0.00281	CcSEcCtD
Oxymorphone—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000841	0.00281	CcSEcCtD
Oxymorphone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00084	0.00281	CcSEcCtD
Oxymorphone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000828	0.00277	CcSEcCtD
Oxymorphone—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000823	0.00275	CcSEcCtD
Oxymorphone—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000822	0.00275	CcSEcCtD
Oxymorphone—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000818	0.00274	CcSEcCtD
Oxymorphone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000818	0.00274	CcSEcCtD
Oxymorphone—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000808	0.0027	CcSEcCtD
Oxymorphone—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000806	0.0027	CcSEcCtD
Oxymorphone—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000803	0.00269	CcSEcCtD
Oxymorphone—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000796	0.00266	CcSEcCtD
Oxymorphone—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000796	0.00266	CcSEcCtD
Oxymorphone—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000795	0.00266	CcSEcCtD
Oxymorphone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000792	0.00265	CcSEcCtD
Oxymorphone—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00078	0.00261	CcSEcCtD
Oxymorphone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000771	0.00258	CcSEcCtD
Oxymorphone—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000766	0.00256	CcSEcCtD
Oxymorphone—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000766	0.00256	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00076	0.00254	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000756	0.00253	CcSEcCtD
Oxymorphone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.00251	CcSEcCtD
Oxymorphone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00075	0.00251	CcSEcCtD
Oxymorphone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000749	0.00251	CcSEcCtD
Oxymorphone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000748	0.0025	CcSEcCtD
Oxymorphone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000748	0.0025	CcSEcCtD
Oxymorphone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000738	0.00247	CcSEcCtD
Oxymorphone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000738	0.00247	CcSEcCtD
Oxymorphone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000738	0.00247	CcSEcCtD
Oxymorphone—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000735	0.00246	CcSEcCtD
Oxymorphone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000735	0.00246	CcSEcCtD
Oxymorphone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000735	0.00246	CcSEcCtD
Oxymorphone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000735	0.00246	CcSEcCtD
Oxymorphone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000734	0.00246	CcSEcCtD
Oxymorphone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000734	0.00246	CcSEcCtD
Oxymorphone—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000734	0.00245	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00245	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00245	CcSEcCtD
Oxymorphone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000723	0.00242	CcSEcCtD
Oxymorphone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000721	0.00241	CcSEcCtD
Oxymorphone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000721	0.00241	CcSEcCtD
Oxymorphone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00072	0.00241	CcSEcCtD
Oxymorphone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000719	0.0024	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000718	0.0024	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000716	0.0024	CcSEcCtD
Oxymorphone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000707	0.00237	CcSEcCtD
Oxymorphone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000707	0.00237	CcSEcCtD
Oxymorphone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000706	0.00236	CcSEcCtD
Oxymorphone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000696	0.00233	CcSEcCtD
Oxymorphone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000696	0.00233	CcSEcCtD
Oxymorphone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000694	0.00232	CcSEcCtD
Oxymorphone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000693	0.00232	CcSEcCtD
Oxymorphone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000693	0.00232	CcSEcCtD
Oxymorphone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000693	0.00232	CcSEcCtD
Oxymorphone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000693	0.00232	CcSEcCtD
Oxymorphone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00231	CcSEcCtD
Oxymorphone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00231	CcSEcCtD
Oxymorphone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000687	0.0023	CcSEcCtD
Oxymorphone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000687	0.0023	CcSEcCtD
Oxymorphone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000685	0.00229	CcSEcCtD
Oxymorphone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00228	CcSEcCtD
Oxymorphone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000679	0.00227	CcSEcCtD
Oxymorphone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000678	0.00227	CcSEcCtD
Oxymorphone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000673	0.00225	CcSEcCtD
Oxymorphone—Naloxone—ALB—chronic obstructive pulmonary disease	0.00067	0.093	CrCbGaD
Oxymorphone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00067	0.00224	CcSEcCtD
Oxymorphone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00223	CcSEcCtD
Oxymorphone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000661	0.00221	CcSEcCtD
Oxymorphone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000661	0.00221	CcSEcCtD
Oxymorphone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000657	0.0022	CcSEcCtD
Oxymorphone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000657	0.0022	CcSEcCtD
Oxymorphone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000656	0.00219	CcSEcCtD
Oxymorphone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000655	0.00219	CcSEcCtD
Oxymorphone—OPRM1—Opioid Signalling—PDE4A—chronic obstructive pulmonary disease	0.000654	0.0189	CbGpPWpGaD
Oxymorphone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00218	CcSEcCtD
Oxymorphone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000649	0.00217	CcSEcCtD
Oxymorphone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000646	0.00216	CcSEcCtD
Oxymorphone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00216	CcSEcCtD
Oxymorphone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00064	0.00214	CcSEcCtD
Oxymorphone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00064	0.00214	CcSEcCtD
Oxymorphone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.00213	CcSEcCtD
Oxymorphone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000636	0.00213	CcSEcCtD
Oxymorphone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00063	0.00211	CcSEcCtD
Oxymorphone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00063	0.00211	CcSEcCtD
Oxymorphone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000629	0.0021	CcSEcCtD
Oxymorphone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000629	0.0021	CcSEcCtD
Oxymorphone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000626	0.0021	CcSEcCtD
Oxymorphone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000624	0.00209	CcSEcCtD
Oxymorphone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000622	0.00208	CcSEcCtD
Oxymorphone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000622	0.00208	CcSEcCtD
Oxymorphone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00062	0.00207	CcSEcCtD
Oxymorphone—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000617	0.0178	CbGpPWpGaD
Oxymorphone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000616	0.00206	CcSEcCtD
Oxymorphone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000614	0.00205	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00061	0.00204	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00061	0.00204	CcSEcCtD
Oxymorphone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00061	0.00204	CcSEcCtD
Oxymorphone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00061	0.00204	CcSEcCtD
Oxymorphone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00061	0.00204	CcSEcCtD
Oxymorphone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000605	0.00202	CcSEcCtD
Oxymorphone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000605	0.00202	CcSEcCtD
Oxymorphone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000605	0.00202	CcSEcCtD
Oxymorphone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000605	0.00202	CcSEcCtD
Oxymorphone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.00202	CcSEcCtD
Oxymorphone—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000603	0.00202	CcSEcCtD
Oxymorphone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000599	0.0173	CbGpPWpGaD
Oxymorphone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000598	0.002	CcSEcCtD
Oxymorphone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000597	0.002	CcSEcCtD
Oxymorphone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000595	0.00199	CcSEcCtD
Oxymorphone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000594	0.00199	CcSEcCtD
Oxymorphone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000592	0.00198	CcSEcCtD
Oxymorphone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000591	0.00198	CcSEcCtD
Oxymorphone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000588	0.00197	CcSEcCtD
Oxymorphone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000585	0.00196	CcSEcCtD
Oxymorphone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000583	0.00195	CcSEcCtD
Oxymorphone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000583	0.00195	CcSEcCtD
Oxymorphone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000582	0.00195	CcSEcCtD
Oxymorphone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.00194	CcSEcCtD
Oxymorphone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000579	0.00194	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000578	0.00193	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000578	0.00193	CcSEcCtD
Oxymorphone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000578	0.00193	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000576	0.00193	CcSEcCtD
Oxymorphone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000576	0.00193	CcSEcCtD
Oxymorphone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000571	0.00191	CcSEcCtD
Oxymorphone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000571	0.00191	CcSEcCtD
Oxymorphone—OPRM1—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.000567	0.0164	CbGpPWpGaD
Oxymorphone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000566	0.00189	CcSEcCtD
Oxymorphone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000562	0.00188	CcSEcCtD
Oxymorphone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000562	0.00188	CcSEcCtD
Oxymorphone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000559	0.00187	CcSEcCtD
Oxymorphone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000559	0.00187	CcSEcCtD
Oxymorphone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000559	0.00187	CcSEcCtD
Oxymorphone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000559	0.00187	CcSEcCtD
Oxymorphone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000557	0.00186	CcSEcCtD
Oxymorphone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000552	0.00185	CcSEcCtD
Oxymorphone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000552	0.00185	CcSEcCtD
Oxymorphone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00055	0.00184	CcSEcCtD
Oxymorphone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00184	CcSEcCtD
Oxymorphone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000549	0.00184	CcSEcCtD
Oxymorphone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000549	0.00184	CcSEcCtD
Oxymorphone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000548	0.00183	CcSEcCtD
Oxymorphone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000548	0.00183	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000546	0.00183	CcSEcCtD
Oxymorphone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00053	0.00177	CcSEcCtD
Oxymorphone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000528	0.00177	CcSEcCtD
Oxymorphone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000528	0.00177	CcSEcCtD
Oxymorphone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000521	0.00174	CcSEcCtD
Oxymorphone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.00174	CcSEcCtD
Oxymorphone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00052	0.00174	CcSEcCtD
Oxymorphone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000519	0.00174	CcSEcCtD
Oxymorphone—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000516	0.0149	CbGpPWpGaD
Oxymorphone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00051	0.00171	CcSEcCtD
Oxymorphone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000507	0.0017	CcSEcCtD
Oxymorphone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000507	0.0017	CcSEcCtD
Oxymorphone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0005	0.00167	CcSEcCtD
Oxymorphone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.00167	CcSEcCtD
Oxymorphone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000497	0.00166	CcSEcCtD
Oxymorphone—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000496	0.0143	CbGpPWpGaD
Oxymorphone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000493	0.00165	CcSEcCtD
Oxymorphone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00165	CcSEcCtD
Oxymorphone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00049	0.00164	CcSEcCtD
Oxymorphone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000484	0.00162	CcSEcCtD
Oxymorphone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000484	0.00162	CcSEcCtD
Oxymorphone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.0016	CcSEcCtD
Oxymorphone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00159	CcSEcCtD
Oxymorphone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000474	0.00158	CcSEcCtD
Oxymorphone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00158	CcSEcCtD
Oxymorphone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000468	0.00156	CcSEcCtD
Oxymorphone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000468	0.00156	CcSEcCtD
Oxymorphone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000464	0.0134	CbGpPWpGaD
Oxymorphone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000458	0.00153	CcSEcCtD
Oxymorphone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.00153	CcSEcCtD
Oxymorphone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.0015	CcSEcCtD
Oxymorphone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00045	0.0015	CcSEcCtD
Oxymorphone—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000448	0.013	CbGpPWpGaD
Oxymorphone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000445	0.00149	CcSEcCtD
Oxymorphone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000445	0.00149	CcSEcCtD
Oxymorphone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000443	0.00148	CcSEcCtD
Oxymorphone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.00148	CcSEcCtD
Oxymorphone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000443	0.00148	CcSEcCtD
Oxymorphone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000442	0.00148	CcSEcCtD
Oxymorphone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000442	0.00148	CcSEcCtD
Oxymorphone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00044	0.00147	CcSEcCtD
Oxymorphone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000436	0.00146	CcSEcCtD
Oxymorphone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00145	CcSEcCtD
Oxymorphone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.00142	CcSEcCtD
Oxymorphone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000422	0.00141	CcSEcCtD
Oxymorphone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.00141	CcSEcCtD
Oxymorphone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.00141	CcSEcCtD
Oxymorphone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.0014	CcSEcCtD
Oxymorphone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00042	0.0014	CcSEcCtD
Oxymorphone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.0014	CcSEcCtD
Oxymorphone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000412	0.00138	CcSEcCtD
Oxymorphone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00138	CcSEcCtD
Oxymorphone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.00136	CcSEcCtD
Oxymorphone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000405	0.00135	CcSEcCtD
Oxymorphone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.0117	CbGpPWpGaD
Oxymorphone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000399	0.00133	CcSEcCtD
Oxymorphone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00133	CcSEcCtD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL17A—chronic obstructive pulmonary disease	0.000395	0.0114	CbGpPWpGaD
Oxymorphone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00039	0.0013	CcSEcCtD
Oxymorphone—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000383	0.0111	CbGpPWpGaD
Oxymorphone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000383	0.00128	CcSEcCtD
Oxymorphone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.00126	CcSEcCtD
Oxymorphone—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000375	0.0108	CbGpPWpGaD
Oxymorphone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000374	0.00125	CcSEcCtD
Oxymorphone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00124	CcSEcCtD
Oxymorphone—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000367	0.0106	CbGpPWpGaD
Oxymorphone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000366	0.00122	CcSEcCtD
Oxymorphone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000364	0.00122	CcSEcCtD
Oxymorphone—OPRM1—IL4-mediated signaling events—IL10—chronic obstructive pulmonary disease	0.000362	0.0105	CbGpPWpGaD
Oxymorphone—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000361	0.0104	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00036	0.0104	CbGpPWpGaD
Oxymorphone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00119	CcSEcCtD
Oxymorphone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000354	0.00118	CcSEcCtD
Oxymorphone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000352	0.0102	CbGpPWpGaD
Oxymorphone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.00116	CcSEcCtD
Oxymorphone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000343	0.00115	CcSEcCtD
Oxymorphone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000341	0.00114	CcSEcCtD
Oxymorphone—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000337	0.00976	CbGpPWpGaD
Oxymorphone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000327	0.0011	CcSEcCtD
Oxymorphone—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000324	0.00938	CbGpPWpGaD
Oxymorphone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000321	0.00107	CcSEcCtD
Oxymorphone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000316	0.00106	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000315	0.00912	CbGpPWpGaD
Oxymorphone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000313	0.00105	CcSEcCtD
Oxymorphone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00102	CcSEcCtD
Oxymorphone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00102	CcSEcCtD
Oxymorphone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.00102	CcSEcCtD
Oxymorphone—OPRD1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000304	0.00878	CbGpPWpGaD
Oxymorphone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.0003	0.001	CcSEcCtD
Oxymorphone—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000297	0.00859	CbGpPWpGaD
Oxymorphone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000295	0.000988	CcSEcCtD
Oxymorphone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000985	CcSEcCtD
Oxymorphone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000293	0.00847	CbGpPWpGaD
Oxymorphone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000289	0.000968	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000964	CcSEcCtD
Oxymorphone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.000944	CcSEcCtD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000282	0.00814	CbGpPWpGaD
Oxymorphone—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000281	0.00813	CbGpPWpGaD
Oxymorphone—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000279	0.00805	CbGpPWpGaD
Oxymorphone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000931	CcSEcCtD
Oxymorphone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000916	CcSEcCtD
Oxymorphone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000913	CcSEcCtD
Oxymorphone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000272	0.000908	CcSEcCtD
Oxymorphone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000904	CcSEcCtD
Oxymorphone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000269	0.0009	CcSEcCtD
Oxymorphone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000267	0.00771	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000267	0.00771	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000266	0.0077	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—CD8A—chronic obstructive pulmonary disease	0.000266	0.00768	CbGpPWpGaD
Oxymorphone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000265	0.000887	CcSEcCtD
Oxymorphone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.000847	CcSEcCtD
Oxymorphone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000842	CcSEcCtD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000247	0.00714	CbGpPWpGaD
Oxymorphone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000245	0.00709	CbGpPWpGaD
Oxymorphone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000819	CcSEcCtD
Oxymorphone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000809	CcSEcCtD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000241	0.00698	CbGpPWpGaD
Oxymorphone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.000807	CcSEcCtD
Oxymorphone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000802	CcSEcCtD
Oxymorphone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.000802	CcSEcCtD
Oxymorphone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000796	CcSEcCtD
Oxymorphone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00682	CbGpPWpGaD
Oxymorphone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000767	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000761	CcSEcCtD
Oxymorphone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.000761	CcSEcCtD
Oxymorphone—OPRM1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000225	0.0065	CbGpPWpGaD
Oxymorphone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000739	CcSEcCtD
Oxymorphone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000221	0.00638	CbGpPWpGaD
Oxymorphone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000736	CcSEcCtD
Oxymorphone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000736	CcSEcCtD
Oxymorphone—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000219	0.00634	CbGpPWpGaD
Oxymorphone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.0062	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000212	0.00612	CbGpPWpGaD
Oxymorphone—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000211	0.00611	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000209	0.00604	CbGpPWpGaD
Oxymorphone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000686	CcSEcCtD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000202	0.00583	CbGpPWpGaD
Oxymorphone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000668	CcSEcCtD
Oxymorphone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000658	CcSEcCtD
Oxymorphone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000637	CcSEcCtD
Oxymorphone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000615	CcSEcCtD
Oxymorphone—OPRD1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000184	0.00531	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000179	0.00517	CbGpPWpGaD
Oxymorphone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000592	CcSEcCtD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000177	0.00511	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000177	0.00511	CbGpPWpGaD
Oxymorphone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000586	CcSEcCtD
Oxymorphone—Headache—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000583	CcSEcCtD
Oxymorphone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000174	0.00502	CbGpPWpGaD
Oxymorphone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00501	CbGpPWpGaD
Oxymorphone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000553	CcSEcCtD
Oxymorphone—OPRK1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000161	0.00466	CbGpPWpGaD
Oxymorphone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.0045	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000155	0.00448	CbGpPWpGaD
Oxymorphone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.00444	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000151	0.00438	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000151	0.00435	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000149	0.00432	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000143	0.00414	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000141	0.00407	CbGpPWpGaD
Oxymorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00405	CbGpPWpGaD
Oxymorphone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.004	CbGpPWpGaD
Oxymorphone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000138	0.00399	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000136	0.00394	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000135	0.00391	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000133	0.00384	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000132	0.00382	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000131	0.00379	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000129	0.00373	CbGpPWpGaD
Oxymorphone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00365	CbGpPWpGaD
Oxymorphone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00364	CbGpPWpGaD
Oxymorphone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000121	0.0035	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000119	0.00343	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000118	0.00342	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000117	0.00338	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000115	0.00333	CbGpPWpGaD
Oxymorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00328	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000113	0.00327	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000112	0.00324	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000112	0.00323	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000111	0.00321	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00011	0.00317	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000109	0.00317	CbGpPWpGaD
Oxymorphone—OPRD1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000109	0.00315	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000104	0.003	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000104	0.003	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000103	0.00298	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000103	0.00297	CbGpPWpGaD
Oxymorphone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000102	0.00296	CbGpPWpGaD
Oxymorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00294	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000101	0.00292	CbGpPWpGaD
Oxymorphone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.0029	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.0001	0.0029	CbGpPWpGaD
Oxymorphone—OPRK1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	9.56e-05	0.00276	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.55e-05	0.00276	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.43e-05	0.00273	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.23e-05	0.00267	CbGpPWpGaD
Oxymorphone—OPRD1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	9.2e-05	0.00266	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.12e-05	0.00264	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.11e-05	0.00263	CbGpPWpGaD
Oxymorphone—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.1e-05	0.00263	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.03e-05	0.00261	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.01e-05	0.00261	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.77e-05	0.00254	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.67e-05	0.00251	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.54e-05	0.00247	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.27e-05	0.00239	CbGpPWpGaD
Oxymorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.25e-05	0.00239	CbGpPWpGaD
Oxymorphone—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	8.25e-05	0.00239	CbGpPWpGaD
Oxymorphone—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	8.08e-05	0.00234	CbGpPWpGaD
Oxymorphone—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.06e-05	0.00233	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8e-05	0.00231	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.9e-05	0.00228	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.7e-05	0.00223	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.7e-05	0.00223	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.63e-05	0.00221	CbGpPWpGaD
Oxymorphone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.59e-05	0.00219	CbGpPWpGaD
Oxymorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.31e-05	0.00211	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.26e-05	0.0021	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.18e-05	0.00207	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.07e-05	0.00204	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.99e-05	0.00202	CbGpPWpGaD
Oxymorphone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.98e-05	0.00202	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.91e-05	0.002	CbGpPWpGaD
Oxymorphone—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	6.82e-05	0.00197	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.76e-05	0.00195	CbGpPWpGaD
Oxymorphone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.71e-05	0.00194	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.68e-05	0.00193	CbGpPWpGaD
Oxymorphone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.61e-05	0.00191	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.52e-05	0.00188	CbGpPWpGaD
Oxymorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.41e-05	0.00185	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.06e-05	0.00175	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.03e-05	0.00174	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.95e-05	0.00172	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.92e-05	0.00171	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.82e-05	0.00168	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.71e-05	0.00165	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.57e-05	0.00161	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.57e-05	0.00161	CbGpPWpGaD
Oxymorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.42e-05	0.00157	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.39e-05	0.00156	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.29e-05	0.00153	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.19e-05	0.0015	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.12e-05	0.00148	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.11e-05	0.00148	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.09e-05	0.00147	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.03e-05	0.00145	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.96e-05	0.00143	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.89e-05	0.00141	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.88e-05	0.00141	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.83e-05	0.0014	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.64e-05	0.00134	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.63e-05	0.00134	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.62e-05	0.00134	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.56e-05	0.00132	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.47e-05	0.00129	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.38e-05	0.00127	CbGpPWpGaD
Oxymorphone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.38e-05	0.00127	CbGpPWpGaD
Oxymorphone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.32e-05	0.00125	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.31e-05	0.00125	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.13e-05	0.00119	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.13e-05	0.00119	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.07e-05	0.00118	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.06e-05	0.00117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.92e-05	0.00113	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.79e-05	0.00109	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.77e-05	0.00109	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.57e-05	0.00103	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.57e-05	0.00103	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.53e-05	0.00102	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.49e-05	0.00101	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.48e-05	0.00101	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.43e-05	0.000991	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.32e-05	0.00096	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.23e-05	0.000934	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.15e-05	0.00091	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.12e-05	0.000903	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.06e-05	0.000886	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.02e-05	0.000873	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.86e-05	0.000826	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.84e-05	0.000821	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.81e-05	0.000811	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.76e-05	0.000798	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.74e-05	0.000792	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.73e-05	0.00079	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.59e-05	0.000749	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.54e-05	0.000734	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.51e-05	0.000724	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.49e-05	0.00072	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.4e-05	0.000693	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.34e-05	0.000675	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.33e-05	0.000674	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.31e-05	0.000669	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.27e-05	0.000657	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.23e-05	0.000644	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.12e-05	0.000612	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.11e-05	0.000611	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.1e-05	0.000608	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.09e-05	0.000604	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.02e-05	0.000585	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.99e-05	0.000576	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.9e-05	0.00055	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000549	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.88e-05	0.000544	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.000543	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.83e-05	0.000529	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.75e-05	0.000505	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.000495	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.69e-05	0.000488	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.67e-05	0.000482	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.61e-05	0.000464	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000456	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.55e-05	0.000447	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.53e-05	0.000441	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.48e-05	0.000428	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.48e-05	0.000427	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.41e-05	0.000408	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.41e-05	0.000407	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.37e-05	0.000396	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.34e-05	0.000387	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000381	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000375	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.26e-05	0.000364	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.25e-05	0.000362	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.24e-05	0.000359	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.23e-05	0.000357	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.23e-05	0.000355	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.00035	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.2e-05	0.000348	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.19e-05	0.000344	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000332	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.13e-05	0.000327	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.000324	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.1e-05	0.000319	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.08e-05	0.000313	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.04e-05	0.0003	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.000298	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.02e-05	0.000294	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.48e-06	0.000274	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.33e-06	0.00027	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.14e-06	0.000264	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.08e-06	0.000263	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.61e-06	0.000249	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.49e-06	0.000245	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.31e-06	0.00024	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.91e-06	0.000229	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	7.79e-06	0.000225	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.68e-06	0.000222	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.5e-06	0.000217	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.46e-06	0.000216	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.03e-06	0.000203	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.1e-06	0.000147	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.87e-06	0.000141	CbGpPWpGaD
